Balaxi Pharmaceuticals (NSE:BALAXI) Other Net Income (Loss) : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Other Net Income (Loss)?

Balaxi Pharmaceuticals's Other Net Income (Loss) for the three months ended in Dec. 2024 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Balaxi Pharmaceuticals's quarterly Other Net Income (Loss) increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil) but then declined from Sep. 2024 (₹0 Mil) to Dec. 2024 (₹0 Mil).

Balaxi Pharmaceuticals's annual Other Net Income (Loss) increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then declined from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Balaxi Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Balaxi Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Other Net Income (Loss) Chart

Balaxi Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Get a 7-Day Free Trial

Balaxi Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	0.01	-

Balaxi Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Balaxi Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Balaxi Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Balaxi Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 3rd Floor, Hyderabad, TG, IND, 500 096

Website

https://www.balaxipharma.in

Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Geographically it earns key revenue from Guatemala.

Balaxi Pharmaceuticals Headlines

No Headlines